Table 1.
No. of patients | |
---|---|
Patients (male/female) | 24 (15/9) |
Age (years) (range) | 51 (19–72) |
Previous renal replacement therapy | |
″Haemodialysis | ″8 |
″Peritoneal dialysis | ″12 |
″None | ″4 |
Primary kidney disease | |
″Polycystic kidney disease | ″5 |
″Hypertensive nephropathy | ″3 |
″Diabetic nephropathy | ″2 |
″Obstructive nephropathy | ″2 |
″Nephrolithiasis | 2 |
″Glomerulonephritis | 1 |
″Other/unknown | 9 |
Transplantation type | |
″Living related | ″16 |
″Living unrelated | ″5 |
″Deceased donor | ″3 |
Transplantation number | |
″First | ″ 19 |
″Second | ″5 |
Number of HLA mismatches | |
″HLA-A | 0·92 ± 0·12 |
″HLA-B | 1·08 ± 0·10 |
″HLA-DR | 0·96 ± 0·14 |
Recipient negative for CMV, donor positive | ″2 |
Patients with PRA > 5% | 3 |
Duration of cold ischaemia (h) (median and range) | 0·5 (0·2–25·8) |
PRA, panel reactive antibodies.